Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia

NeuroReport

Volumn 23, Issue 4, 2012, Pages 224-227

  Shan, Dan ^a   Haroutunian, Vahram ^b   Meador Woodruff, James H ^a,c   McCullumsmith, Robert E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

adenosine; equilibrative nucleoside transporter 1; excitatory amino acid transporter; glutamate; schizophrenia

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER TYPE 1; UNCLASSIFIED DRUG;

AGED; ANTERIOR CINGULATE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SUPERIOR TEMPORAL GYRUS;

AGED; AGED, 80 AND OVER; AGING; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; FEMALE; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 84857182186     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3283500987     Document Type: Article

References (20)

1. Huerta I, McCullumsmith RE, Haroutunian V, Gimenez-Amaya JM, Meador-Woodruff JH. Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia. Synapse 2006; 59:394-402.
2. Chen J, Rinaldo L, Lim SJ, Young H, Messing RO, Choi DS. The type 1 equilibrative nucleoside transporter regulates anxiety-like behavior in mice. Genes Brain Behav 2007; 6:776-783. (Pubitemid 350043949)
3. Governo RJ, Deuchars J, Baldwin SA, King AE. Localization of the NBMPRsensitive equilibrative nucleoside transporter, ENT1, in the rat dorsal root ganglion and lumbar spinal cord. Brain Res 2005; 1059:129-138. (Pubitemid 41457310)
4. Goff DC, Coyle JT. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001; 158: 1367-1377. (Pubitemid 32847232)
5. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 2004; 447:735-743. (Pubitemid 38241459)
6. Wu J, Lee MR, Choi S, Kim T, Choi DS. ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes. Alcohol Clin Exp Res 2010; 34:1110-1117.
7. Hammond JC, McCullumsmith RE, Funk AJ, Haroutunian V, Meador-Woodruff JH. Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia. Neuropsychopharmacology 2010; 35:2110-2119.
8. Bauer DE, Haroutunian V, McCullumsmith RE, Meador-Woodruff JH. Expression of four housekeeping proteins in elderly patients with schizophrenia. J Neural Transm 2009; 116:487-491.
9. Jennings LL, Hao C, Cabrita MA, Vickers MF, Baldwin SA, Young JD, et al. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology 2001; 40:722-731. (Pubitemid 32323996)
10. Benarroch EE. Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease. Neurology 2008; 70:231-236.
11. Wilson NR, Kang J, Hueske EV, Leung T, Varoqui H, Murnick JG, et al. Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J Neurosci 2005; 25:221-234.
12. Bauer D, Jackson JG, Krizman-Genda EN, Montoya MM, Geragosian C, Robinson MB. Interactions between GLAST, the Na +/K + ATPase, and mitochondria: potential implications for astroglial glutamate metabolism. Society for neuroscience annual meeting 2011. Washington, DC: Society for Neuroscience; 2011.
13. McCullumsmith RE, Clinton SM, Meador-Woodruff JH. Schizophrenia as a disorder of neuroplasticity. Int Rev Neurobiol 2004; 59:19-45. (Pubitemid 39752410)
14. Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am J Psychiatry 2001; 158:1393-1399. (Pubitemid 32847237)
15. Clinton SM, Meador-Woodruff JH. Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology 2004; 29:1353-1362. (Pubitemid 38780658)
16. Katsel P, Davis KL, Gorman JM, Haroutunian V. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophr Res 2005; 77:241-252. (Pubitemid 41112217)
17. Kristiansen LV, Bakir B, Haroutunian V, Meador-Woodruff JH. Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia. Schizophr Res 2010; 119:198-209.
18. Oni-Orisan A, Kristiansen LV, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE. Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia. Biol Psychiatry 2008; 63:766-775.
19. De Souza IE, McBean GJ, Meredith GE. Chronic haloperidol treatment impairs glutamate transport in the rat striatum. Eur J Pharmacol 1999; 382:139-142. (Pubitemid 29488747)
20. Melone M, Vitellaro-Zuccarello L, Vallejo-Illarramendi A Perez-Samartin A, Matute C, Cozzi A, et al. The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine. Mol Psychiatry 2001; 6: 380-386. (Pubitemid 32566086)